Tag:
Taligen Therapeutics
Latest Headlines
Latest Headlines
Booming Alexion blueprints new space for fast-growing staff
Fast-growing Alexion Pharmaceuticals is hiring. After snagging Taligen Therapeutics near the beginning of this year for $111 million plus a milestone package, the biotech says that it now plans to
Alexion snaps up Taligen for $111M-plus, creates translational unit
The promising protein drug developer Taligen Therapeutics is being snapped up by Alexion Pharmaceuticals for $111 million upfront and an undisclosed package of milestones for six of its drug
Taligen gets $10M cash injection for rare disease programs
Taligen Therapeutics has hit another milestone on its journey in search of new therapies for a broad array of inflammatory and immune diseases. The Cambridge, MA-based developer has snagged a $10
